FDA's guidance on investigating out-of-specification (OOS) test results calls for failure investigations, and notes that much of it can also help when examining out-of-trend (OOT) results. This 90-minute webinar explains FDA requirements and guidelines for handling out-of-trend results in the pharmaceutical laboratory.
You'll review the relevant FDA regulations and the final Guidance for Industry on investigating OOS results, how OOS and OOT results differ, and how to write SOPs for OOT situations and laboratory failures. The session covers what to investigate and how, retesting, and evaluating results with historical data, QC samples and product control charts.
It also explains how to find the root cause, develop CAPA plans, prevent OOS results before they happen, and document OOS, OOT, investigations, root causes and CAPA in an FDA-compliant way.
Most companies have procedures for OOS results but not for OOT situations, and many are unsure how to interpret and apply FDA's guidance to them. Managing OOT results well also helps you avoid time-consuming OOS investigations later.
This session suits lab supervisors and managers, QA managers and staff, pharmaceutical R&D and documentation personnel, consultants, contract laboratories and CROs.
Most companies have procedures for OOS results but not for OOT situations, and many are unsure how to interpret and apply FDA's guidance to them. Managing OOT results well also helps you avoid time-consuming OOS investigations later.
This session suits lab supervisors and managers, QA managers and staff, pharmaceutical R&D and documentation personnel, consultants, contract laboratories and CROs.
Kelly Thomas
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Project Management For Administrative Professionals
Elevate Your Workplace Wellness: 10 Critical Wellness Facto…
Managing Complex Projects - Project Management
Onboarding is NOT Orientation - How to Improve the New Empl…
Utilizing HR Metrics to Illustrate & Improve Human Resource…
Negotiating Skills For Professional Results - Winning Strat…
NEW Nacha Rule - Third-Party Sender (TPS) Roles and Respons…
FDA Technology Modernization Action Plan (TMAP) and Impact …
Paying and Receiving Payments for Referrals: You Can Go to …
Construction Lending And Real Credit Administration: Evalua…
Human Factors Usability Studies Following ISO 62366 and FDA…
Validation Statistics for Non-Statisticians
Thriving in a Hybrid Workplace: Keys to Leadership and Team…
Excel Power Skills: Master Functions, Formulas, and Macros …
Batch Record Review and Product Release
Discover how Emotional Intelligence turns AI from a technic…
Female to Female Hostility @Workplace: All you Need to Know
Copilot and HR: An Introduction for HR Professionals
ChatGPT for HR - Build HR Policy Framework and Strategy
Excel Spreadsheets; Develop and Validate for 21 CFR Part 11…
Major cGMP Issues: FDA Concerns in 2026
Language is Code - Intro to AI - Generative AI - ChatGPT an…
The Perfect Storm Coming to Healthcare: Value Based Care Me…
I-9 Audits: Strengthening Your Immigration Compliance Strat…
Pivot tables beginner to advanced + 20 advanced Pivot table…
Emotional Intelligence: Mastering the Emotions of Great Lea…